Summary
JPMorgan Chase & Co. has announced the election of Alicia Boler Davis as a new director, effective March 20, 2023. Ms. Davis brings significant experience as the current Chief Executive Officer of Alto Pharmacy. Her appointment is a strategic move to enhance the board's expertise and will also extend to leadership roles within key subsidiaries, including JPMorgan Chase Bank, N.A. and JPMorgan Chase Holdings LLC. This board refreshment signals a commitment to ongoing governance improvements and the integration of diverse leadership perspectives. Investors should monitor any future committee assignments for Ms. Davis, as these will provide further insight into her areas of focus and contribution to the company's strategic direction. The appointment is detailed in a press release attached as an exhibit to this filing.
Key Highlights
- 1Alicia Boler Davis elected as a new director, effective March 20, 2023.
- 2Ms. Davis currently serves as the Chief Executive Officer of Alto Pharmacy.
- 3The appointment aims to strengthen the board's expertise and oversight.
- 4Ms. Davis will also serve as a director of JPMorgan Chase Bank, N.A. and a manager of JPMorgan Chase Holdings LLC.
- 5Further director/managerial appointments within other subsidiaries may occur.
- 6The announcement is supported by an attached press release (Exhibit 99.1).